Merck invests in state-of-the-art biotech development facility in Switzerland
The company has announced an investment of € 250 million in a new facility in Corsier-sur-Vevey, Switzerland – the Merck Biotech…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.